Home > Boards > US Listed > Biotechs > Aastrom Biosciences Inc. (ASTM)

The PureGen osteoprogenitor cell allograft facilitates bone fusion,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
EZ2 Member Profile
Member Level Grandfathered Member
Followed By 189
Posts 173,408
Boards Moderated 7
Alias Born 03/31/01
160x600 placeholder
Aastrom Announces Appointment of Zac Taylor as National Sales Director "GlobeNewswire Inc." - 7/14/2014 8:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/11/2014 5:05:19 PM
Aastrom Biosciences Added to Russell Microcap Index "GlobeNewswire Inc." - 6/30/2014 8:30:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 6/27/2014 5:45:36 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/24/2014 12:56:45 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/24/2014 9:14:17 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/24/2014 9:08:42 AM
Aastrom Announces Initiation of Commercial Sales of Bone Marrow by Marrow Donation, LLC "GlobeNewswire Inc." - 6/24/2014 8:45:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 6/16/2014 2:42:59 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 6/16/2014 2:42:42 PM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 6/16/2014 2:39:51 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/16/2014 8:52:05 AM
Aastrom Announces Strategic Plan for Recently Acquired Cell Therapy and Regenerative Medicine Business "GlobeNewswire Inc." - 6/16/2014 6:00:00 AM
Aastrom Announces Investor Conference Call and Webcast June 16, 2014 at 8:30 AM EDT "GlobeNewswire Inc." - 6/15/2014 6:00:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/13/2014 2:27:11 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/4/2014 8:45:20 AM
Aastrom Announces Appointment of Gerard Michel as Chief Financial Officer and Vice President, Corporate Development "GlobeNewswire Inc." - 6/4/2014 8:45:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/2/2014 8:45:48 AM
Aastrom Completes Acquisition of Sanofi's Cell Therapy and Regenerative Medicine Business "GlobeNewswire Inc." - 6/2/2014 8:45:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 5/19/2014 12:08:04 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 5/19/2014 12:06:09 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 5/16/2014 9:28:50 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 5/16/2014 9:28:15 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/15/2014 4:12:38 PM
Aastrom Biosciences Reports First-Quarter 2014 Financial Results "GlobeNewswire Inc." - 5/15/2014 4:05:00 PM
EZ2 Member Level Grandfathered Member Tuesday, 10/05/10 09:40:31 AM
Re: mkendra post# 2573
Post # of 4206 
Quote:
The PureGen osteoprogenitor cell allograft facilitates bone fusion, and is marketed exclusively by Alphatec Spine.

PureGen is an adult stem cell that provides cellular and growth factors needed for osteogenesis, without the potential complications of autograft.

Applied at the site of a musculoskeletal defect, PureGen mimics the regenerative environment of youthful tissues by increasing the concentration of stem cells available to repair tissue and build bone.


“There are those who don’t know and those who don’t know they don’t know.”

John Kenneth Galbraith
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist